Search results for "ALAT"

showing 10 items of 4241 documents

Inhaled nitric oxide as a rescue therapy in a preterm neonate with severe pulmonary hypertension: a case report

2018

Abstract Background Inhaled nitric oxide (iNO) has been approved for the treatment of persistent pulmonary hypertension of the newborn (PPHN) in term and near-term newborns. Its role in the management of persistent pulmonary hypertension in preterm infants is not clear. Although guidelines do not exist, some studies have shown that iNO could be used as a rescue therapy in preterm neonate with severe pulmonary hypertension. Case presentation We describe the case of a preterm neonate, born at 30 + 1 weeks of gestation, with hypoxic respiratory failure not responding to maximal conventional therapy. On the third day of life echocardiography showed severe pulmonary hypertension with right to le…

medicine.medical_specialtyHypertension PulmonaryRight-to-left shuntDay of lifeCase ReportInfant Premature DiseasesNitric OxidePulmonary hypertensionNitric oxide03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRescue therapy030225 pediatricsInternal medicinemedicine.arteryAdministration InhalationHumansMedicine030212 general & internal medicinebusiness.industryPersistent pulmonary hypertensionPreterm neonatelcsh:RJ1-570Infant Newbornlcsh:PediatricsGeneral Medicinemedicine.diseasePulmonary hypertensionBronchodilator AgentschemistryRespiratory failureCardiologyGestationFemalebusinessInfant PrematureInhaled nitric oxideItalian Journal of Pediatrics
researchProduct

Inhaled anesthesia in neurosurgery: Still a role?

2021

In patients undergoing craniotomy, general anesthesia should be addressed to warrant good hypnosis, immobility, and analgesia, to ensure systemic and cerebral physiological status and provide the best possible surgical field. Regarding craniotomies, it is unclear if there are substantial differences in providing general anesthesia using total intravenous anesthesia (TIVA) or balanced anesthesia (BA) accomplished using the third generation halogenates. New evidence highlighted that the last generation of halogenated agents has possible advantages compared with intravenous drugs: rapid induction, minimal absorption and metabolization, reproducible pharmacokinetic, faster recovery, cardioprote…

medicine.medical_specialtyHypnosisBalanced Anesthesiabusiness.industrymedicine.medical_treatmentHemodynamicsBrainAnesthesia GeneralNeurosurgical ProceduresThird generationAnesthesiology and Pain MedicineOpioidAnesthesiaAnesthesia Recovery PeriodmedicineHumansIn patientNeurosurgeryAnesthesia InhalationbusinessDesfluraneNeurophysiological MonitoringCraniotomymedicine.drugBest Practice & Research Clinical Anaesthesiology
researchProduct

Tomographic evaluation of dentoskeletal effects of rapid maxillary expansion using Haas and Hyrax palatal expanders in children : a randomized clinic…

2020

Background Rapid maxillary expansion (RME) is a usual procedure for correcting the transversal maxillary deficiency. Among the most used appliances are the Haas type (tooth-tissue-borne) and Hyrax (tooth-borne) whose main difference is the design. This study aimed to evaluate the dentoskeletal effects of RME using two different expanders in children. Material and methods The sample was composed of 42 children of both gender presenting unilateral or bilateral posterior crossbite with mean age 9.49 (SD± 1.35). Patients were randomized into two groups according to the type of expander: Hyrax (n= 21, 9 boys and 12 girls) and Haas (n= 21, 11 boys and 10 girls). Multiplanar coronal and axial slic…

medicine.medical_specialtyHyraxOrthodontics030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallaw0502 economics and businessMedicineRapid maxillary expansionPalatal Expansion TechniqueGeneral DentistryOrthodonticsbiologybusiness.industryResearch05 social sciencesbiology.organism_classification:CIENCIAS MÉDICAS [UNESCO]Dental archmedicine.anatomical_structureCoronal planeOrthopedic surgeryUNESCO::CIENCIAS MÉDICASPosterior teeth050211 marketingbusiness
researchProduct

Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study

2017

Abstract Background Mitoxantrone (MX) has been used as second line therapy for aggressive multiple sclerosis (MS). Potential cardiotoxic effects of MX limit its use; a cumulative dose of up to 100 mg/m2, has been long considered relatively safe. We calculated the frequency of cardiac side effects in MS patients treated with MX. Methods We performed a cohort study including all MS patients treated with MX at the Neurological Department of the University Hospital of Palermo, Italy. Two hundred-sixty-four MS patients diagnosed according to validated criteria were included and followed-up until the end of September 2010. Patients were treated with MX as a second line therapy if they had no prev…

medicine.medical_specialtyImmunologyHeart failureComorbidity030204 cardiovascular system & hematologylcsh:RC346-429Multiple sclerosis03 medical and health sciences0302 clinical medicineInternal medicinemedicineImmunology and AllergyMyocardial infarctionlcsh:Neurology. Diseases of the nervous systemMitoxantroneEjection fractionmedicine.diagnostic_testCumulative dosebusiness.industryComorbidity Multiple sclerosis Heart failure Mitoxantrone Therapymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareNeurologyHeart failureCohortPhysical therapySettore MED/26 - NeurologiaTherapyNeurology (clinical)MitoxantronebusinessElectrocardiography030217 neurology & neurosurgeryCohort studymedicine.drug
researchProduct

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study.

2020

Abstract Patients with Philadelphia-negative myeloproliferative neoplasm (MPN) are prone to the development of second cancers, but the factors associated with these events have been poorly explored. In an international nested case-control study, we recruited 647 patients with carcinoma, nonmelanoma skin cancer, hematological second cancer, and melanoma diagnosed concurrently or after MPN diagnosis. Up to 3 control patients without a history of cancer and matched with each case for center, sex, age at MPN diagnosis, date of diagnosis, and MPN disease duration were included (n = 1234). Cases were comparable to controls for MPN type, driver mutations and cardiovascular risk factors. The freque…

medicine.medical_specialtyImmunologyKaplan-Meier EstimateGene mutationBiochemistryGastroenterologyMyeloproliferative neoplasms03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingInternal medicineCarcinomaMedicineHumansPhiladelphia ChromosomeMyeloproliferative neoplasmMyeloproliferative Disordersbusiness.industryCase-control studyCancerfood and beveragesMyeloproliferative neoplasmssecond cancersarterial eventsNeoplasms Second PrimaryThrombosisCell BiologyHematologyOdds ratioArteriesmedicine.diseasesecond cancersThrombosisSettore MED/15 - MALATTIE DEL SANGUEarterial events030220 oncology & carcinogenesisCase-Control StudiesMultivariate Analysis/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSkin cancerbusiness030215 immunologyFollow-Up StudiesBlood
researchProduct

Anästhesiologisches Management bei der Versorgung von Mukoviszidose-Patienten1

2000

Objective: Improvements in the management of patients with cystic fibrosis (CF) result in increased life expectancy. Thus it is likely that anesthetists will see this patients with increasing frequency. This study describes our experiences in the anesthetic management of CF patients. Methods: We descriptively and retrospectively reviewed the records of all CF patients from 1981 until 1997 who underwent elective surgery in our department of ear, nose and throat and in whom general anesthesia was required. Results: 199 anesthetics in 53 patients were reviewed. Premedication with midazolam (0.4±0.07 mg/kg) were given orally in 163 of the 199 anesthetics (82%). In 45 anesthetics the induction w…

medicine.medical_specialtyInhalationbusiness.industryRespiratory diseaseGeneral MedicinePerioperativeCritical Care and Intensive Care Medicinemedicine.diseasePulmonary function testingSurgeryAnesthesiology and Pain Medicinemedicine.anatomical_structureAnesthesiaEmergency MedicinemedicineMidazolamPremedicationElective surgerybusinessNosemedicine.drugains · Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
researchProduct

Anestheticography: Clinical Applications

2009

medicine.medical_specialtyInhalationbusiness.industrymedicineIntensive care medicinebusiness
researchProduct

Oral findings in Midline Syndrome: a case report and literature review

2010

We describe a female patient with a midline syndrome. The patient presents agenesis of the corpus callosum, encephalocele, iris coloboma, hypertelorism, submucosal cleft palate and dental anomalies. Despite being very characteristic, her phenotypical traits do not coincide exactly with those reported to date in the literature. The karyotype and the molecular cytogenetic study do not show mutations. We identify the presence of dental anomalies in the mother and other family members, not being identified MSX1 and PAX9 mutations that could the related with their etiology. Despite the fact that dental agenesis has been related to a large number of other malformation syndromes and congenital con…

medicine.medical_specialtyIrisEncephalocele03 medical and health sciences0302 clinical medicinestomatognathic systemMidline syndromeDental abnormalitiesmedicineHumansAbnormalities MultipleHypertelorismChildAgenesis of the corpus callosumGeneral DentistryEncephalocele030304 developmental biology0303 health sciencesHypertelorismTooth Abnormalitiesbusiness.industryDental agenesisSyndrome:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologyIris coloboma3. Good healthSurgeryCleft PalateColobomastomatognathic diseasesPhenotypeOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASEtiologyFemaleSurgeryMalformacionsAgenesis of Corpus Callosummedicine.symptombusinessMalformacions dentalsHuman abnormalitiesPAX9030217 neurology & neurosurgery
researchProduct

NAD- and NADP-linked dehydrogenases in the sciatic nerve of rats injected with di-isopropylfluorophosphate.

1966

medicine.medical_specialtyIsoflurophateL-Lactate DehydrogenaseChemistryGeneral NeuroscienceAnatomyGlucosephosphate DehydrogenaseIn Vitro TechniquesNADSciatic NerveRatsEndocrinologyMalate DehydrogenaseInternal medicinemedicineAnimalsNeurology (clinical)Sciatic nerveNAD+ kinaseMolecular BiologyNADPDevelopmental BiologyBrain research
researchProduct

Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate

2019

Informazione non disponibile

medicine.medical_specialtyLetteracute respiratory failureRespiratory ratebusiness.industryMEDLINElcsh:Medical emergencies. Critical care. Intensive care. First aidOxygen Inhalation Therapylcsh:RC86-88.9high flow nasal therapyCritical Care and Intensive Care MedicineCannula Dyspnea Humans Oxygen Inhalation Therapy Patient Comfort Respiratory RateDyspneaRespiratory RateEmergency medicineNIVmedicineCannulaHumansAcute respiratory failurePatient ComfortCOTHigh flowbusiness
researchProduct